Related Experiment Video
Updated: Feb 7, 2026

Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis
Published on: January 21, 2020
Double robust estimation for multiple unordered treatments and clustered observations: Evaluating drug-eluting
Sherri Rose1, Sharon-Lise Normand1,2
1Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, U.S.A.
Abstract:
Postmarket comparative effectiveness and safety analyses of therapeutic treatments typically involve large observational cohorts. We propose double robust machine learning estimation techniques for implantable medical device evaluations where there are more than two unordered treatments and patients are clustered in hospitals. This flexible approach also accommodates high-dimensional covariates drawn from clinical databases. The Massachusetts Data Analysis Center percutaneous coronary intervention cohort is used to assess the composite outcome of 10 drug-eluting stents among adults implanted with at least one drug-eluting stent in Massachusetts. We find remarkable discrimination between stents. A simulation study designed to mimic this coronary intervention cohort is also presented and produced similar results.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease V: Interprofessional Care
Bioequivalence of Drugs: Drugs with Multiple Indications
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures

